EUVIMEDEUVIMED entdecken
Crossref

Bayesian analysis of the effect of exosomes in a mouse xenograft model of chronic myeloid leukemia

Rafael Martínez-Fonseca, Cruz Vargas-De-León, Ramón Reyes-Carreto, Flaviano Godínez-Jaimes

Mathematical Biosciences and Engineering · 2023

DOI: 10.3934/mbe.2023864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mathematical Biosciences and Engineering, 2023. Verfasst von Rafael Martínez-Fonseca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Matemáticas, Universidad Autónoma de Guerrero, Ciudad Universitaria s/n Chilpancingo, Guerrero, Mexico. Hauptthemen laut MEDLINE: Exosomes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this work is to estimate the effect of Imatinib, exosomes, and Imatinib-exosomes mixture in chronic myeloid leukemia (CML). For this purpose, mathematical models based on Gompertzian and logistic growth differential equations were proposed. The models contained parameters representing the effects of the three components on CML proliferation. Parameters estimation was performed under the Bayesian statistical approach. Experimental data reported in the literature were used, corresponding to four trials of a human leukemia xenograft in BALB/c female rats over a period of forty days. The models were fitted to the following growth dynamics: normal tumor growth, growth with exosomes, growth with Imatinib, and growth with exosomes-Imatinib mixture. For the proposed logistic growth model, it was determined that when using Imatinib treatment the growth rate is 0.93 (95% CrI: 84.33–99.64) slower and reduces the tumor volume to approximately 10% (95% CrI : 8.67–10.81). In the presence of exosome treatment, the growth rate is 0.83 (95% CrI: 1.52–16.59) faster and the tumor volume is expanded by 40% (95% CrI: 25.36–57.28). Finally, in the presence of Imatinib-exosomes mixture treatment, the growth rate is 0.82 (95% CrI: 76.87–88.51) slower and the tumor volume is reduced by 95% (95% CrI: 86.76–99.85). It is concluded that the presence of exosomes partially inactivates the effect of the Imatinib drug on tumor growth in a mouse xenograft model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAntineoplastic AgentsHumansFemaleMiceRatsAnimalsImatinib MesylateBayes TheoremHeterograftsDisease Models, AnimalDrug Resistance, Neoplasm

Stichwörter der Autor:innen

Bayesian estimationImatinibchronic myeloid leukemiaexosomestumor growth models

Substanzen

Imatinib MesylateAntineoplastic Agents

Autor:innen und Institutionen

  • Facultad de Matemáticas, Universidad Autónoma de Guerrero, Ciudad Universitaria s/n Chilpancingo, Guerrero, Mexico.
  • División de Investigación, Hospital Juárez de Mexico, Ciudad de México 07760, Mexico.
  • Sección de Estudios de Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, Ciudad de Mexico 11340, Mexico.

Zitieren

APA

Martínez-Fonseca, R., Vargas-De-León, C., Reyes-Carreto, R., & Godínez-Jaimes, F. (2023). Bayesian analysis of the effect of exosomes in a mouse xenograft model of chronic myeloid leukemia. Mathematical Biosciences and Engineering. https://doi.org/10.3934/mbe.2023864

Vancouver

Martínez-Fonseca R, Vargas-De-León C, Reyes-Carreto R, Godínez-Jaimes F. Bayesian analysis of the effect of exosomes in a mouse xenograft model of chronic myeloid leukemia. Mathematical Biosciences and Engineering. 2023. doi:10.3934/mbe.2023864

BibTeX
@article{MartnezFonseca2023,
  author = {Martínez-Fonseca, Rafael and Vargas-De-León, Cruz and Reyes-Carreto, Ramón and Godínez-Jaimes, Flaviano},
  title = {Bayesian analysis of the effect of exosomes in a mouse xenograft model of chronic myeloid leukemia},
  journal = {Mathematical Biosciences and Engineering},
  year = {2023},
  doi = {10.3934/mbe.2023864}
}
Kostenlos starten →